Time-related impact of distal embolisation on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation
Giuseppe De Luca1*, MD; C. Michael Gibson2, MD; Kurt Huber3, MD; Dariusz Dudek4, MD; Donald Cutlip5, MD; Uwe Zeymer6, MD; Maryann Gyongyosi7, MD; Francesco Bellandi8, MD; Marko Noc9, MD; Hans-Richard Arntz10, MD; Mauro Maioli8, MD; Gioel Gabrio Secco1, MD; Simona Zorman9, MD; H. Mesquita Gabriel11, MD; Ayse Emre12, MD; Tomasz Rakowski4, MD; Arnoud W.J. van’t Hof13, MD; on behalf of the EGYPT cooperation
1. Division of Cardiology, “Maggiore della Carità” Hospital, Eastern Piedmont University, Novara, Italy; 2. TIMI Study Group, Beth Israel Deaconess Medical Center, Boston, MA, USA; 3. 3rd Department of Medicine (Cardiology and Emergency
Aims: Considerable interest has been focused in recent years on the role of distal embolisation as a major determinant of impaired reperfusion a